Medidata Solutions Inc (MDSO)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Medidata Solutions Inc (MDSO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012295
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. The company offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations. The company markets and sells its products through direct sales force, contract research organization and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc (MDSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Medidata Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Akros Pharma Enters into Agreement with Medidata 12
Auris Medical Enters Into Agreement With Medidata Solutions 13
Acquisition 14
Medidata Solutions to Acquire Mytrus 14
Medidata Solutions Completes Acquisition Of Clinical Force 15
Medidata Solutions Inc – Key Competitors 16
Medidata Solutions Inc – Key Employees 17
Medidata Solutions Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Strategy And Business Planning 21
Sep 27, 2017: Medidata Opens New, Larger London EMEA Headquarters 21
Financial Announcements 22
Oct 26, 2017: Medidata Reports Record Third Quarter 2017 Results 22
Apr 26, 2017: Medidata Reports Record First Quarter 2017 Results 24
Feb 09, 2017: Medidata Reports Record Full-Year and Fourth Quarter 2016 Results 26
Oct 25, 2016: Medidata Reports Record Third Quarter 2016 Results 28
Jul 20, 2016: Medidata Reports Record Second Quarter 2016 Results 29
Apr 21, 2016: Medidata Reports Record First Quarter 2016 Results 30
Feb 10, 2016: Medidata Reports Full-Year and Fourth Quarter 2015 Results 32
Corporate Communications 33
Apr 26, 2016: Christian Hebenstreit Joins Medidata as Managing Director of EMEA, Driving Growth and Development Across the Region 33
Legal and Regulatory 34
Jan 06, 2016: DATATRAK Announces Settlement of Patent Litigation 34
Government and Public Interest 35
Apr 12, 2016: Medidata and Tufts Center for the Study of Drug Development Publish Research Findings on Implications of Mid-Study Clinical Trial Protocol Changes 35
Product News 36
Feb 25, 2016: Medidata’s Cloud Technology Powers U.S. Government Research on Drug Development Costs 36
Jan 26, 2016: ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO 37
Other Significant Developments 38
Jul 20, 2017: “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Medidata Solutions Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Medidata Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Akros Pharma Enters into Agreement with Medidata 12
Auris Medical Enters Into Agreement With Medidata Solutions 13
Medidata Solutions to Acquire Mytrus 14
Medidata Solutions Completes Acquisition Of Clinical Force 15
Medidata Solutions Inc, Key Competitors 16
Medidata Solutions Inc, Key Employees 17
Medidata Solutions Inc, Other Locations 19
Medidata Solutions Inc, Subsidiaries 20

★海外企業調査レポート[Medidata Solutions Inc (MDSO)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Tata Power Co Ltd:発電所・企業SWOT分析
    The Tata Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • Autogrill S.p.A.:企業の戦略・SWOT・財務情報
    Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Calumet Specialty Products Partners LP (CLMT):企業の財務・戦略的SWOT分析
    Calumet Specialty Products Partners LP (CLMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Global Foundries Inc:企業の戦略・SWOT・財務情報
    Global Foundries Inc - Strategy, SWOT and Corporate Finance Report Summary Global Foundries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alexion Pharmaceuticals Inc (ALXN)-製薬・医療分野:企業M&A・提携分析
    Summary Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic d …
  • Concert Pharmaceuticals Inc (CNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Concert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology company which discovers and develops small molecule drugs. The company develops its products using its deuterated chemical entity (DCE) platform to develop novel therapeutics for autoimmune and inflammato …
  • Pentair plc (PNR)-石油・ガス分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Janssen Biotech, Inc.:企業のM&A・事業提携・投資動向
    Janssen Biotech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Biotech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Nufarm Ltd (NUF):企業の財務・戦略的SWOT分析
    Nufarm Ltd (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The Timken Company:企業の戦略・SWOT・財務分析
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • StemBioSys Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Tesla Motors, Inc.:企業の戦略・SWOT・財務情報
    Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆